netrashetty
Netra Shetty
Organisational Structure of Pfizer : Pfizer Incorporated (NYSE: PFE) is a pharmaceutical company, ranking number one in sales in the world. The company is based in New York City, with its research headquarters in Groton, Connecticut. It produces Lipitor (atorvastatin, used to lower blood cholesterol); the neuropathic pain/fibromyalgia drug Lyrica (pregabalin); the oral antifungal medication Diflucan (fluconazole), the antibiotic Zithromax (azithromycin), Viagra (sildenafil) for erectile dysfunction, and the anti-inflammatory Celebrex (celecoxib) (also known as Celebra in some countries outside the USA and Canada, mainly in South America). Its headquarters are in Midtown Manhattan, New York City.[3]
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.[4]
Pfizer pleaded guilty in 2009 to the largest health care fraud in U.S. history and received the largest criminal penalty ever levied for illegal marketing of four of its drugs. Called a repeat offender, this was Pfizer's fourth such settlement with the U.S. Department of Justice in the previous ten years.[5][6] On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.[7] The deal was completed on October 15, 2009
CEO
Ian Read
Chairman
George Lorch
Director
William Gray
Director
Robert Burt
Director
Dennis Ausiello
Director
Suzanne Johnson
Director
James Kilts
Director
Don Cornwell
Director
Anthony Burns
Director
Frances Fergusson
Director
Michael Brown
Director
Stephen Sanger
Director
John Mascotte
Lead Director
Constance Horner
Chairman Emeritus
William Steere
CFO
Frank d'Amelio
Animal Health
JA
Capsugel
GD
Consumer Healthcare
PS
Emerging Markets
JMH
Established Products
David Simmons
Nutrition
EM
Primary Care
OB
Specialty Care
GG
Medical
FLH
Diversified Businesses
CR
Research & Development
MD
Compliance
DL
Legal
AS
Oncology Business
GN
Policy & Communication
SS
Manufacturing
Natale Ricciardi
Research & Development
MM
Development Strategy & Innov...
KP
Human Resources
Mary McLeod
Global Procurement
LM
Investor Relations
CT
Legal, Europe
FG
Deputy Legal
RJ
Pfizer's shares were made a component of the Dow Jones Industrial Average on April 8, 2004.[4]
Pfizer pleaded guilty in 2009 to the largest health care fraud in U.S. history and received the largest criminal penalty ever levied for illegal marketing of four of its drugs. Called a repeat offender, this was Pfizer's fourth such settlement with the U.S. Department of Justice in the previous ten years.[5][6] On January 26, 2009, Pfizer agreed to buy pharmaceutical giant Wyeth for US$68 billion, a deal financed with cash, shares and loans.[7] The deal was completed on October 15, 2009
CEO
Ian Read
Chairman
George Lorch
Director
William Gray
Director
Robert Burt
Director
Dennis Ausiello
Director
Suzanne Johnson
Director
James Kilts
Director
Don Cornwell
Director
Anthony Burns
Director
Frances Fergusson
Director
Michael Brown
Director
Stephen Sanger
Director
John Mascotte
Lead Director
Constance Horner
Chairman Emeritus
William Steere
CFO
Frank d'Amelio
Animal Health
JA
Capsugel
GD
Consumer Healthcare
PS
Emerging Markets
JMH
Established Products
David Simmons
Nutrition
EM
Primary Care
OB
Specialty Care
GG
Medical
FLH
Diversified Businesses
CR
Research & Development
MD
Compliance
DL
Legal
AS
Oncology Business
GN
Policy & Communication
SS
Manufacturing
Natale Ricciardi
Research & Development
MM
Development Strategy & Innov...
KP
Human Resources
Mary McLeod
Global Procurement
LM
Investor Relations
CT
Legal, Europe
FG
Deputy Legal
RJ
Last edited by a moderator: